HIF1A and neoplasm: For instance, use of these agents for cancer chemotherapy increases tumor hypoxia via a hypoxia-inducible factor-1α (HIF-1α) signaling pathway (Miyazaki et al., 2014; Shi et al., 2017; Ueda et al., 2017; de Almeida et al., 2020).